168 related articles for article (PubMed ID: 20189692)
1. Cytotoxicity of new alkylamino- and phenylamino-containing polyfluorinated derivatives of 1,4-naphthoquinone.
Zakharova OD; Ovchinnikova LP; Goryunov LI; Troshkova NM; Shteingarts VD; Nevinsky GA
Eur J Med Chem; 2010 Jun; 45(6):2321-6. PubMed ID: 20189692
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of new n-butylamino and sulfur-containing derivatives of polyfluorinated 1,4-naphthoquinone.
Zakharova OA; Goryunov LI; Troshkova NM; Ovchinnikova LP; Shteingarts VD; Nevinsky GA
Eur J Med Chem; 2010 Jan; 45(1):270-4. PubMed ID: 19883955
[TBL] [Abstract][Full Text] [Related]
3. Cytotoxicity of new polyfluorinated 1,4-naphtoquinones with diverse substituents in the quinone moiety.
Zakharova OD; Ovchinnikova LP; Goryunov LI; Troshkova NM; Shteingarts VD; Nevinsky GA
Bioorg Med Chem; 2011 Jan; 19(1):256-60. PubMed ID: 21134760
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization and antiproliferative activity of 1,2-naphthoquinone and its derivatives.
Shukla S; Srivastava RS; Shrivastava SK; Sodhi A; Kumar P
Appl Biochem Biotechnol; 2012 Jul; 167(5):1430-45. PubMed ID: 22258648
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, anticancer activity, and molecular modeling of 1,4-naphthoquinones that inhibit MKK7 and Cdc25.
Schepetkin IA; Karpenko AS; Khlebnikov AI; Shibinska MO; Levandovskiy IA; Kirpotina LN; Danilenko NV; Quinn MT
Eur J Med Chem; 2019 Dec; 183():111719. PubMed ID: 31563013
[TBL] [Abstract][Full Text] [Related]
6. Fluorinated Cpd 5, a pure arylating K-vitamin derivative, inhibits human hepatoma cell growth by inhibiting Cdc25 and activating MAPK.
Kar S; Wang M; Ham SW; Carr BI
Biochem Pharmacol; 2006 Nov; 72(10):1217-27. PubMed ID: 16930563
[TBL] [Abstract][Full Text] [Related]
7. 1,4-Naphthoquinone is a potent inhibitor of human cancer cell growth and angiogenesis.
Kayashima T; Mori M; Yoshida H; Mizushina Y; Matsubara K
Cancer Lett; 2009 Jun; 278(1):34-40. PubMed ID: 19168278
[TBL] [Abstract][Full Text] [Related]
8. Novel naphthoquinone and quinolinedione inhibitors of CDC25 phosphatase activity with antiproliferative properties.
Braud E; Goddard ML; Kolb S; Brun MP; Mondésert O; Quaranta M; Gresh N; Ducommun B; Garbay C
Bioorg Med Chem; 2008 Oct; 16(19):9040-9. PubMed ID: 18789703
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of novel rhinacanthins and related anticancer naphthoquinone esters.
Kongkathip N; Luangkamin S; Kongkathip B; Sangma C; Grigg R; Kongsaeree P; Prabpai S; Pradidphol N; Piyaviriyagul S; Siripong P
J Med Chem; 2004 Aug; 47(18):4427-38. PubMed ID: 15317455
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel naphthoquinone fused cyclic aminoalkylphosphonates and aminoalkylphosphonic monoester.
Wang B; Miao ZW; Wang J; Chen RY; Zhang XD
Amino Acids; 2008 Aug; 35(2):463-8. PubMed ID: 17665273
[TBL] [Abstract][Full Text] [Related]
11. Genotoxicity of aminohydroxynaphthoquinones in bacteria, yeast, and Chinese hamster lung fibroblast cells.
da Costa Medina LF; Viau CM; Moura DJ; Saffi J; Stefani V; Brandelli A; Henriques JA
Mutat Res; 2008 Feb; 650(2):140-9. PubMed ID: 18178518
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and pharmacophore modeling of naphthoquinone derivatives with cytotoxic activity in human promyelocytic leukemia HL-60 cell line.
Pérez-Sacau E; Díaz-Peñate RG; Estévez-Braun A; Ravelo AG; García-Castellano JM; Pardo L; Campillo M
J Med Chem; 2007 Feb; 50(4):696-706. PubMed ID: 17249647
[TBL] [Abstract][Full Text] [Related]
13. Biological evaluation of donor-acceptor aminonaphthoquinones as antitumor agents.
Benites J; Valderrama JA; Bettega K; Pedrosa RC; Calderon PB; Verrax J
Eur J Med Chem; 2010 Dec; 45(12):6052-7. PubMed ID: 20980080
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, anticancer activity and QSAR study of 1,4-naphthoquinone derivatives.
Prachayasittikul V; Pingaew R; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2014 Sep; 84():247-63. PubMed ID: 25019480
[TBL] [Abstract][Full Text] [Related]
15. First synthesis and anticancer activity of novel naphthoquinone amides.
Pradidphol N; Kongkathip N; Sittikul P; Boonyalai N; Kongkathip B
Eur J Med Chem; 2012 Mar; 49():253-70. PubMed ID: 22280818
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and anticancer evaluation of naphthoquinone esters with 2'-cyclopentyl and 2'-cyclohexyl substituents.
Kongkathip N; Pradidphol N; Hasitapan K; Kongkathip B
Biosci Biotechnol Biochem; 2010; 74(6):1205-14. PubMed ID: 20530913
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the cytotoxic activities of naturally occurring hydroxyanthraquinones and hydroxynaphthoquinones.
Cui XR; Tsukada M; Suzuki N; Shimamura T; Gao L; Koyanagi J; Komada F; Saito S
Eur J Med Chem; 2008 Jun; 43(6):1206-15. PubMed ID: 17949858
[TBL] [Abstract][Full Text] [Related]
18. Antitumor activity of two derivatives from 2-acylamine-1, 4-naphthoquinone in mice bearing S180 tumor.
Bezerra DP; Alves AP; de Alencar NM; Mesquita Rde O; Lima MW; Pessoa C; de Moraes MO; Lopes JN; Lopes NP; Costa-Lotufo LV
J Exp Ther Oncol; 2008; 7(2):113-21. PubMed ID: 18771085
[TBL] [Abstract][Full Text] [Related]
19. Antitumoral activity of new polyamine-naphthoquinone conjugates.
Esteves-Souza A; Lucio KA; Da Cunha AS; Da Cunha Pinto A; Da Silva Lima EL; Camara CA; Vargas MD; Gattass CR
Oncol Rep; 2008 Jul; 20(1):225-31. PubMed ID: 18575741
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and cytotoxicity of 1,2-disubstituted naphth[2,3-d]imidazole-4,9-diones and related compounds.
Kuo SC; Ibuka T; Huang LJ; Lien JC; Yean SR; Huang SC; Lednicer D; Morris-Natschke S; Lee KH
J Med Chem; 1996 Mar; 39(7):1447-51. PubMed ID: 8691475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]